SCHLACKMAN SCOTT 4

What Happened Scott Schlackman, a director of Medifast, Inc. (MED), was granted 11,680 restricted stock units (RSUs) on May 26, 2026. The Form 4 reports the acquisition at $0.00 (a grant), which reflects an award of units rather than a cash purchase. The RSUs were granted under the Medifast Director's Deferred Compensation Plan and are scheduled to vest in full on May 26, 2027.

Key Details

• Transaction date: 2026-05-26; Transaction type: Award/Grant (code A).
• Shares/units granted: 11,680 RSUs; reported acquisition price: $0.00; total reported value on Form 4: $0.
• Vesting: RSUs will vest in full on 2027-05-26 (per footnote).
• Plan/source: Granted under the Medifast Director's Deferred Compensation Plan and issued from the Amended and Restated 2012 Share Incentive Plan.
• Shares owned after transaction: Not specified in this filing.
• Filing timeliness: Form 4 was filed May 28, 2026 for the May 26 transaction (filed within the typical 2‑business‑day window).

Context

• This was a compensation-related grant, not an open‑market purchase or sale; such awards are common for board pay and don’t necessarily signal immediate insider sentiment about the stock.
• Each RSU represents the right to receive one share upon vesting (per the footnote). No tax‑withholding or sale‑on‑vesting details were included in this filing.